Skip to main content
Premium Trial:

Request an Annual Quote

OMT Licenses Sangamo’s ZFP Technology for Transgenic Animal Research

NEW YORK (GenomeWeb News) – Sangamo BioSciences today announced that it has entered into a licensing agreement with Palo Alto, Calif.-based Open Monoclonal Technologies, under which OMT obtained non-exclusive, worldwide rights to develop transgenic animals using Sangamo’s proprietary zinc finger DNA-binding technology.
 
In exchange, Richmond, Calif.-based Sangamo will receive an upfront license fee, future payments contingent on clinical development milestones, a share of payments that OMT receives from its sub-licensees, and royalties on sale’s related to the ZFP technology.
 
OMT will have the right to buy out these royalty payments with a lump sum payment for each OMT product. Other financial details of the agreement were not disclosed.
 
Zinc finger DNA-binding proteins belong to a group of proteins called transcription factors that bind DNA and help regulate its expression in the cell. Sangamo’s engineered ZFPs and sequence specific ZFP nucleases (ZFN) are designed to precisely modify the genes to which they bind.
 
Applying this technology to transgenic animal research may improve the ease and efficiency of generating site-specific mutations in animal models. This approach, in turn, could broaden transgenic animal research beyond the traditional mouse model, Sangamo Vice President of Research Philip Gregory said in a statement.
 
“The frequency and precision of ZFN-mediated genome-editing, in combination with the ability to design ZFNs against potentially any gene, opens up the potential to more easily generate transgenic animals of any species,” Gregory said.

The Scan

US Booster Eligibility Decision

The US CDC director recommends that people at high risk of developing COVID-19 due to their jobs also be eligible for COVID-19 boosters, in addition to those 65 years old and older or with underlying medical conditions.

Arizona Bill Before Judge

The Arizona Daily Star reports that a judge is weighing whether a new Arizona law restricting abortion due to genetic conditions is a ban or a restriction.

Additional Genes

Wales is rolling out new genetic testing service for cancer patients, according to BBC News.

Science Papers Examine State of Human Genomic Research, Single-Cell Protein Quantification

In Science this week: a number of editorials and policy reports discuss advances in human genomic research, and more.